Serena Pelusi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels.

Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels.

Journal: Frontiers in immunology
Published: November 04, 2025

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma.

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma.

Journal: The Journal of clinical investigation
Published: October 28, 2025

Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunction.

Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunction.

Journal: Cardiovascular diabetology
Published: August 01, 2025

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 09, 2025

Diagnostic Uptake of Targeted Sequencing in Adults With Steatotic Liver Disease and a Suspected Genetic Contribution.

Diagnostic Uptake of Targeted Sequencing in Adults With Steatotic Liver Disease and a Suspected Genetic Contribution.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 06, 2024

PNPLA3 I148M and Hepatocellular Carcinoma.

PNPLA3 I148M and Hepatocellular Carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 30, 2024

MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.

MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.

Journal: Cardiovascular diabetology
Published: May 28, 2024

Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease.

Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease.

Journal: Trends in molecular medicine
Published: April 17, 2024

Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.

Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.

Journal: Nature medicine
Published: January 24, 2024

Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women.

Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women.

Journal: Clinical and translational medicine
Published: December 06, 2023

Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD.

Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 26, 2023

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.

Journal: Hepatology (Baltimore, Md.)
Published: August 19, 2023
Showing 1-12 of 66

Last Updated: 09/26/2026